DarioHealth Corp. (DRIO)

DarioHealth Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.84	21.8	27.76	36.8	49.36	35.81
Short-Term Investments	3.31	4.21	0.7	-	-	-
Cash & Short-Term Investments	31.15	26.02	28.46	36.8	49.36	35.81
Cash Growth	-2.36%	-8.59%	-22.65%	-25.45%	37.84%	25.25%
Accounts Receivable	1.45	2.14	4.8	3.16	6.42	1.31
Other Receivables	2.06	0.53	0.29	0.25	0.24	0.08
Receivables	3.51	2.67	5.09	3.41	6.66	1.79
Inventory	3.54	4.32	4.75	5.06	7.96	6.23
Prepaid Expenses	-	1.58	1.79	1.54	0.91	1.59
Other Current Assets	0.29	0.49	0.43	0.53	0.65	0.19
Total Current Assets	38.49	35.07	40.53	47.33	65.52	45.61
Property, Plant & Equipment	1.41	1.27	1.77	1.87	1.99	0.99
Goodwill	57.43	57.43	57.43	41.64	41.64	41.64
Other Intangible Assets	14.53	15.93	18.76	5.4	9.92	12.46
Long-Term Deferred Charges	-	0.18	0.07	0.06	0.04	-
Other Long-Term Assets	0.58	0.21	0.33	0.09	0.08	0.08
Total Assets	112.43	110.08	118.88	96.39	119.19	100.77

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.7	2.93	3.05	1.13	2.32	5.11
Accrued Expenses	5.15	5.25	6.05	6.3	6.59	7.81
Current Portion of Long-Term Debt	-	-	5.45	3.95	8.82	-
Current Portion of Leases	0.56	0.43	0.5	0.11	0.29	0.27
Current Unearned Revenue	0.76	0.71	1.58	1	1.32	1.2
Total Current Liabilities	9.17	9.32	16.64	12.49	19.35	14.38
Long-Term Debt	31.25	30.75	23.47	24.59	18.11	-
Long-Term Leases	0.65	0.57	0.77	0.89	0.83	0.02
Other Long-Term Liabilities	0.09	1.51	5.99	0.28	0.91	0.83
Total Liabilities	41.16	42.15	46.87	38.25	39.19	15.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	548.37	520	462.36	407.5	365.85	307.56
Retained Earnings	-477.1	-452.08	-390.34	-349.36	-285.85	-222.01
Total Common Equity	71.27	67.92	72.02	58.14	80	85.55
Shareholders' Equity	71.27	67.92	72.02	58.14	80	85.55
Total Liabilities & Equity	112.43	110.08	118.88	96.39	119.19	100.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	32.46	31.75	30.19	29.54	28.05	0.29
Net Cash (Debt)	-1.31	-5.73	-1.73	7.26	21.31	35.52
Net Cash Growth	-	-	-	-65.95%	-40.01%	26.60%
Net Cash Per Share	-0.14	-1.44	-0.71	5.11	18.03	42.82
Filing Date Shares Outstanding	11.29	7.3	2.08	1.47	1.29	1.09
Total Common Shares Outstanding	11.2	6.91	1.92	1.36	1.29	0.83
Working Capital	29.31	25.74	23.89	34.84	46.17	31.23
Book Value Per Share	6.36	9.84	37.52	42.77	62.20	103.24
Tangible Book Value	-0.68	-5.44	-4.17	11.1	28.44	31.45
Tangible Book Value Per Share	-0.06	-0.79	-2.17	8.16	22.11	37.95
Machinery	-	1.07	1.25	1.07	1.1	0.97
Leasehold Improvements	-	0.35	0.34	0.33	0.14	0.15

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error